← Leaderboards
Teodor-Doru Brumeanu Brumeanu
Alliance Pharmaceutical Corporation
$1,526,384
Attributed
$1,526,384
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,526,384 · 3
By mechanism
R01$799,568 · 1
R21$626,817 · 1
R41$99,999 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Insulin Dependent Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$604,626,891
- John M Lachin · George Washington University$152,707,971
- David M Nathan · Massachusetts Institute Of Technology$142,449,293
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Marinella Temprosa · George Washington University$65,495,338
- Rose A Gubitosi-Klug · Case Western Reserve University$65,228,131
Research focus
Insulin Dependent Diabetes MellitusMhc Class Ii AntigenDisease /Disorder Prevention /ControlImmunotherapyDiabetes Mellitus TherapyGenetically Modified AnimalsImmunoregulationLaboratory MouseHelper T LymphocyteAutoantigensImmune Tolerance /UnresponsivenessImmunoglobulin StructureImmunologic MemoryAutoimmune DisorderLongitudinal Animal StudyTissue MosaicismBiological Signal TransductionT Cell ReceptorAge DifferenceGene ExpressionRecombinant ProteinsT LymphocyteHemagglutininImmunomodulators
Grant awards (11)
Prevention Type 1 diabetes by soluble, MHC II-peptide$150,600
R01 · FY2005 · DK
Prevention Type 1 diabetes by soluble, MHC II-peptide$150,600
R01 · FY2004 · DK
NEGATIVE REGULATION OF AUTOREACTIVE T-CELLS$182,746
R21 · FY2003 · DK
Prevention Type 1 diabetes by soluble, MHC II-peptide$80,737
R01 · FY2003 · DK
Prevention Type 1 diabetes by soluble, MHC II-peptide$78,631
R01 · FY2003 · DK
NEGATIVE REGULATION OF AUTOREACTIVE T-CELLS$25,881
R21 · FY2003 · DK
NEGATIVE REGULATION OF AUTOREACTIVE T-CELLS$211,875
R21 · FY2002 · DK
Prevention Type 1 diabetes by soluble, MHC II-peptide$169,500
R01 · FY2002 · DK
NEGATIVE REGULATION OF AUTOREACTIVE T-CELLS$206,315
R21 · FY2001 · DK
Prevention Type 1 diabetes by soluble, MHC II-peptide$169,500
R01 · FY2001 · DK
DOWN-REGULATION OF DIABETOGENIC T-CELLS$99,999
R41 · FY2000 · DK